Announcements Categories Investors Announcements Reports Corporate Governance Share Registry Investor Enquiries Our Board Our Principal Advisors Our Technology Presentations About Us Company Background Intellectual Property December 19, 2023 Genetic Signatures (ASX:GSS) – $6.9m R&D tax incentive received View announcement December 19, 2023 Genetic Signatures (ASX:GSS) – Trading Halt View announcement December 4, 2023 Genetic Signatures (ASX:GSS) – Appendix 3X – Initial Director’s Interest Notice View announcement December 4, 2023 Genetic Signatures (ASX:GSS) – Non Executive Director Appointment – Stephane Chatonsky View announcement November 29, 2023 Genetics Signatures (ASX:GSS)- 2023 AGM Chairman’s Address and CEO Presentation Click here to view 2023 AGM Chairman’s Address and CEO Presentation October 30, 2023 Genetic Signatures (ASX:GSS) – Quarterly update and Appendix 4C View announcement October 27, 2023 Genetics Signatures (ASX:GSS)- 2023 Notice of Annual General Meeting Proxy Form View Announcement September 19, 2023 Genetics Signatures (ASX:GSS) – Investor Presentation View Announcement September 4, 2023 Genetic Signatures (ASX:GSS) – FDA 510(k) Filing in Preparation for US Commercial Launch View Announcement September 4, 2023 Genetic Signatures (ASX:GSS) – FDA 510(k) Application for Gastrointestinal Parasite Detection Kit Submitted View Announcement « Previous 1 2 3 4 5 6 … 23 Next » View GSS ASX Announcements on asx.com.au